Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study

[1]  Y. Nagakura,et al.  Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets , 2022, Prostate international.

[2]  J. Kim,et al.  Association between lower urinary tract symptoms and cigarette smoking or alcohol drinking , 2020, Translational andrology and urology.

[3]  Johannes Scherr,et al.  Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors , 2019, European journal of preventive cardiology.

[4]  Tewogbade Adeoye Adedeji,et al.  Transrectal Doppler Sonography of Benign Prostatic Enlargement in Nigerian Men , 2019, Journal of medical ultrasound.

[5]  N. Ghonge,et al.  Prospective evaluation of prostate with transrectal spectral Doppler with biopsy correlation: a clinicopathologic study. , 2016, The British journal of radiology.

[6]  J. Kim,et al.  Korean clinical practice guideline for benign prostatic hyperplasia , 2016, Investigative and clinical urology.

[7]  Jung Woo Ryu,et al.  Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia , 2006, International neurourology journal.

[8]  A. Memiş,et al.  Effects of Medical Therapy or Surgery on Prostatic and Bladder Resistive Indices in Patients with Benign Prostatic Hyperplasia , 2014, Urologia Internationalis.

[9]  H. Park,et al.  Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil , 2013, The world journal of men's health.

[10]  Hussein A. Aldaqadossi,et al.  The value of measuring the prostatic resistive index vs. pressure-flow studies in the diagnosis of bladder outlet obstruction caused by benign prostatic hyperplasia , 2012, Arab journal of urology.

[11]  H. Shinbo,et al.  Application of Ultrasonography and the Resistive Index for Evaluating Bladder Outlet Obstruction in Patients with Benign Prostatic Hyperplasia , 2011, Current urology reports.

[12]  M. O'Boyle,et al.  Spectral Doppler Signature Waveforms in Ultrasonography: A Review of Normal and Abnormal Waveforms , 2010, Ultrasound quarterly.

[13]  A. Memiş,et al.  Effect of Transurethral Resection of Prostate on Prostatic Resistive Index , 2009, Urologia Internationalis.

[14]  C. Roehrborn,et al.  The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. , 2010, European urology.

[15]  S. Kaplan,et al.  Voiding dysfunction in men: pathophysiology and risk factors , 2008, International Journal of Impotence Research.

[16]  H. Ozdemir,et al.  Measuring resistance index in patients with BPH and lower urinary tract symptoms , 2005, Journal of clinical ultrasound : JCU.

[17]  K. Fujita,et al.  Resistance index in benign prostatic hyperplasia using power doppler imaging and clinical outcomes after transurethral vaporization of the prostate , 2005, International journal of urology : official journal of the Japanese Urological Association.

[18]  C. Roehrborn,et al.  α1-Adrenergic Receptors and Their Inhibitors in Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia , 2004 .

[19]  AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. , 2003, The Journal of urology.

[20]  P. Boyle,et al.  Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. , 2002, Urology.

[21]  K. Fujita,et al.  Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy , 2002, International journal of urology : official journal of the Japanese Urological Association.

[22]  M. Barry,et al.  Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. , 2002, Urology.

[23]  M. Marberger.  Long-Term Effects of Finasteride in Patients with Benign Prostatic Hyperplasia: A Double-Blind, Placebo-Controlled, Multicenter Study , 1998 .

[24]  C. Neumaier,et al.  Normal prostate gland: examination with color Doppler US. , 1995, Radiology.